DALLAS and WASHINGTON D. C., March 21, 2023 — For many people who have heart failure, supervised exercise training is safe and may offer substantial improvement in exercise capacity and quality of ...
BOSTON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies designed to enhance cellular energetics, today announced ...
MINNEAPOLIS — Building on its initial success, researchers expanded a heart failure (HF) guideline-directed medical therapy clinic to treat more people with a wider range of left ventricular ejection ...
Patients with newly diagnosed heart failure with reduced ejection fraction (HFrEF) commonly have improvements in their LVEF, but that doesn’t mean they can let their guard down, data from a large ...
PUMPING FOR LIFE: Ejection fraction is a measure of how much blood your heart is pumping. With each heartbeat, the heart contracts and relaxes. As it contracts, the left and right ventricles eject ...
Panelists discuss how ARNIs like sacubitril-valsartan provide superior outcomes compared with ACE inhibitors in HFrEF (20% reduction in cardiovascular events, 16% mortality reduction), with broad FDA ...
Jim Januzzi, MD, outlines a multitude of drug treatment options for heart failure revolving around patient ejection fraction (EF) status. Ryan Haumschild, PharmD, MS, MBA: As we start to transition ...
Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death among patients with chronic heart failure and a left ventricular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results